Evaluation of the laboratory performance of MolecuTech®REBA MTB-MDR kit for the detection of multidrug resistant tuberculosis. [PDF]
Son ES +6 more
europepmc +1 more source
The threat of multidrug-resistant tuberculosis
openaire +3 more sources
Implementing shorter all-oral treatment durations for multidrug-resistant tuberculosis in the UK: from concept to application. [PDF]
Chavda A +4 more
europepmc +1 more source
Rates and risk factors of monoresistance against isoniazid and multidrug-resistant tuberculosis in Almaty, Kazakhstan. [PDF]
Bartels JGE +7 more
europepmc +1 more source
Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence. [PDF]
LaHood A +22 more
europepmc +1 more source
Influence of Diabetes Mellitus on the Development of Multidrug-Resistant Tuberculosis (MDR-TB) in Relation With Genetic Mutations of <i>M. tuberculosis</i> Isolates in Ethiopia. [PDF]
Seid A, Nureddin S.
europepmc +1 more source
Acceptability of multidrug-resistant tuberculosis preventive treatment: a retrospective survey. [PDF]
MacLean EL +6 more
europepmc +1 more source
Environmental health recommendations for Multidrug-Resistant Tuberculosis in low- and middle-income countries: a systematic review. [PDF]
Nel A, Miller ME, Rother HA.
europepmc +1 more source
Multidrug-resistant tuberculosis (MDR-TB): an evolving threat to the Nigerian health system - a review. [PDF]
Shehu A +19 more
europepmc +1 more source
Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant Tuberculosis. [PDF]
Nguyen TA +10 more
europepmc +1 more source

